3rd Quarter - Report

CAPITOL HILL CONSULTING GROUP for NOVARTIS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

general healthcare issues related to pharmaceutical and biological products; Federal Food, Drug, and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Promoting Innovation and Access to Lifesaving Medicine Act (HR1427/S.726); Pathway for Biosimilars Act (HR1548); Biologics Price Competition and Innovation Act of 2007; drug safety; follow-on biologics; America's Affordable Health Choices Act (HR3200); America's Healthy Future Act

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), H.R. 1548 (111th), S. 726 (111th), H.R. 1427 (111th)

Medicare/Medicaid MMM

General Meidcare and Medicaid issues, including but not limited to, coverage and reimbursement; Physician gifts; Physician Payments Sunshine Act (S.301)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 301 (111th)

Budget/Appropriations BUD

FDA funding issues, generally, FY2010 Labor-HHS Appropriations; FY2010 Supplemental Appropriations; Pandemic vaccine issues; American Recovery and Reinvestment Act (HR1)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th)

Government Issues GOV

general patent issues

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.